Sellas Life Sciences
SLS
$1.35
Share price
5.47%
Change (1 day)
-8.16%
Change (1 year)
Categories
EPS for Sellas Life Sciences (SLS)
EPS in 2023 (TTM): -$1.55
According to Sellas Life Sciences's latest financial reports the company's current EPS (TTM) is -$1.55. In 2022 the company made an earnings per share (EPS) of -$2.23 a decrease over its 2021 EPS that were of -$1.33.
EPS history for Sellas Life Sciences from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.55 | -30.49% |
| 2022 | -$2.23 | 67.67% |
| 2021 | -$1.33 | -37.56% |
| 2020 | -$2.13 | -90.13% |
| 2019 | -$21.59 | -89.39% |
| 2018 | -$203.49 | -66.97% |
| 2017 | -$616.17 | -82.88% |
| 2016 | -$3,600 | -70.73% |
| 2015 | -$12,300 | 36.67% |
| 2014 | -$9,000 | -64.71% |
| 2013 | -$25,500 | 28.79% |
| 2012 | -$19,800 | 109.52% |
| 2011 | -$9,450 | -51.8% |
| 2010 | -$19,607 | -47.05% |
| 2009 | -$37,030 | 16.17% |
| 2008 | -$31,875 | 15.7% |
| 2007 | -$27,549 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 40.65% | 🇺🇸 USA |